Safūf-i Aslussūs: A time-tested polyherbal formulation for the management of Premature Ejaculation- A comprehensive review

  • Waish Ahmad Assistant Professor, Department of Ilmul Advia (Pharmacology), Yunus Fazlani Unani Medical College & Al-Fazlani Unani Hospital, Aurangabad, Maharashtra, India https://orcid.org/0009-0007-0573-8660
  • Javed Inam Siddiqui Professor, Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Hyderabad, Telangana, India
  • Mohammed Abdul Rasheed Naikodi Research Assistant (Chemistry), National Research Institute of Unani Medicine for Skin Disorder, Hyderabad, Telangana, India https://orcid.org/0000-0003-2395-4678
  • Qamrul Islam USMANI Assistant Professor, Department of Ilmul Advia (Pharmacology), Inamdar Unani Medical College and Hospital, Sedam road, Gulbarga, Karnataka, India https://orcid.org/0000-0002-1342-4107

Abstract

Premature Ejaculation (PE) is the most prevalent male sexual complaint worldwide. The ability to control the timing of ejaculation is very important to get pleasure and to maintain the couple’s sexual health. PE is believed to have a multifactorial etiology which mainly includes psychogenic and biogenic factors. Currently available conventional drugs are based on mere assumptions and their use in PE is considered off-label as they have not been approved by the regulatory bodies. On the other hand, Unani System of Medicine has a holistic approach to the prevention and treatment of diseases and provides a line of treatment for PE which is mainly focused on the internal and external use of specific drugs for the restoration of lost powers, elimination of morbid humor and strengthening of organs, muscles, and nerves. In classical Unani literature, PE/Surʻat-i-Inzāl are described in detail under the heading of Amrāz-i-Bāh. In the series of drug therapy a polyherbal Unani formulation, Safūf-i Aslussūs mentioned in different Unani Pharmacopoeias for the management of PE, and Spermatorrhoea is widely prescribed and recommended for a long time by Unani physicians and it is a time-tested drug. This manuscript is an attempt to summarize scientific studies in support of the claim made by Unani physicians regarding Safūf-i Aslussūs.


Keywords: Safoof-i Aslussoos, Surʻat-i-Inzāl, Premature ejaculation, Unani System of Medicine

Keywords: Safoof-i Aslussoos, Surʻat-i-Inzāl, Premature ejaculation, Unani System of Medicine

Downloads

Download data is not yet available.

Author Biographies

Waish Ahmad, Assistant Professor, Department of Ilmul Advia (Pharmacology), Yunus Fazlani Unani Medical College & Al-Fazlani Unani Hospital, Aurangabad, Maharashtra, India

Assistant Professor, Department of Ilmul Advia (Pharmacology), Yunus Fazlani Unani Medical College & Al-Fazlani Unani Hospital, Aurangabad, Maharashtra, India

Javed Inam Siddiqui, Professor, Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Hyderabad, Telangana, India

Professor, Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Hyderabad, Telangana, India

Mohammed Abdul Rasheed Naikodi, Research Assistant (Chemistry), National Research Institute of Unani Medicine for Skin Disorder, Hyderabad, Telangana, India

Research Assistant (Chemistry), National Research Institute of Unani Medicine for Skin Disorder, Hyderabad, Telangana, India

Qamrul Islam USMANI, Assistant Professor, Department of Ilmul Advia (Pharmacology), Inamdar Unani Medical College and Hospital, Sedam road, Gulbarga, Karnataka, India

Assistant Professor, Department of Ilmul Advia (Pharmacology), Inamdar Unani Medical College and Hospital, Sedam road, Gulbarga, Karnataka, India

References

1. Tao P, Coates R, Maycock B. The impact of infertility on sexuality: A literature review. Australas Med J. 2011;4(11):620-7. https://doi.org/10.4066/AMJ.2011.1055
2. Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007;34(4):591-9. https://doi.org/10.1016/j.ucl.2007.08.011 PMid:17983899
3. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The premature ejaculation prevalence and Aatitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51(3):816-24. https://doi.org/10.1016/j.eururo.2006.07.004 PMid:16934919
4. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17(1):39-57. https://doi.org/10.1038/sj.ijir.3901250 PMid:15215881
5. St. Lawrence JS, Madakasira S. Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatry Med. 1992;22(1):77-97. https://doi.org/10.2190/UWP1-CNHH-L0NK-YQY9 PMid:1577550
6. Serefoglu EC, Saitz TR. New insights on premature ejaculation: a review of definition, classification, prevalence and treatment. Asian J Androl. 2012;14(6):822-9. https://doi.org/10.1038/aja.2012.108 PMid:23064688 PMCid:PMC3720102
7. Cooper K, Martyn‐St James M, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, et al. Behavioral therapies for management of premature ejaculation: A systematic review. Sex Med. 2015;3(3):174-88. https://doi.org/10.1002/sm2.65 PMid:26468381 PMCid:PMC4599555
8. Sadeghi-Nejad H, Watson R. Premature ejaculation: current medical treatment and new directions (CME). J Sex Med. 2008;5(5):1037-50. https://doi.org/10.1111/j.1743-6109.2008.00831.x PMid:18439148
9. Gurkan L, Oommen M, Hellstrom WJ. Premature ejaculation: current and future treatments. Asian J Androl. 2008 Jan;10(1):102-9. https://doi.org/10.1111/j.1745-7262.2008.00369.x PMid:18087649
10. Hellstrom WJ. Update on treatments for premature ejaculation. Int J Clin Pract. 2011;65(1):16-26. https://doi.org/10.1111/j.1742-1241.2010.02479.x PMid:21155940
11. Kabīruddīn M. Al-Aksīr, Vol. 2, New Delhi: Aijāz Publishing House; 2003. P.1275-78.
12. Samarqandī N. Sharaḥ Asbāb (Urdu translation by Kabīruddīn M.) 3rd ed. Vol. 3. New Delhi: Idāra Kitāb-us-Shifa; 2014. P. 83-6, 90-92.
13. Anonymous. Standard Unani treatment guidelines for common diseases. Vol.-I. New Delhi: CCRUM; 2014. P. 128-30.
14. Anonymous. Qarābādīn-i-Majīdī. 9th ed. New Delhi: All India Unani Tibbi Conference; 1986. P.169.
15. Anonymous. The Unani Pharmacopoeia of India, Part- 2, Vol. 1. New Delhi: Government of India Ministry of Health & Family Welfare, Department of AYUSH; 2007. P.122.
16. Rani S. A review on Sufoofe sailan: A Polyherbal formulation in the management of Sailan-ur-Rehm (Leucorrhoea). IJUIM. 2018;2(2):117-24. https://doi.org/10.33545/2616454X.2018.v2.i2b.41
17. Anonymous. Qarābādīn-i-Ḥamdard. 3rd ed. New Delhi: Imperial Press; 1971. P.167.
18. Kabīruddīn M. Al-Qarābādīn. 2nd ed. New Delhi: CCRUM; 2006. P.495-560.
19. Khān HS. Ilaj-ul-Amrāz (Urdu translation by Khān HH). 2nd ed. New Delhi: CCRUM; 2005. P.644.
20. Kabīruddīn M. Bayāz-i-Kabīr. 5th ed. Vol. 2. New Delhi: Aijāz Publishing House; 1935. P.158.
21. Arzānī MA. Qarābādīn-i-Qādrī. New Delhi: CCRUM; 2009. P.592.
22. Nadkarni KM. Indian Materia Medica, 3rd ed. Vol. 1. Mumbai: Popular Prakashan; 1976. P. 719-21, 1031-5, 1072-3, 1081-2, 1278-80.
23. Kirtikar KR, Basu BD. Indian Medicinal Plants with Illustrations, 2nd ed. Vol. 2,3,5,6,8. Dehradun: Oriental Enterprises; 2012. P. 626-9, 1021-3, 1368-70, 1508-13, 1987-92, 2668-71.
24. Pullaiah T. Encyclopaedia of World Medicinal Plants, Vol. 2,3,4. New Delhi, Regency Publications; 2006. P. 1019-21, 1204-5, 1645-7, 1689, 1708.
25. Khān MA. Muhīt-i-Aʻzam (Urdu translation) Vol.1-3. New Delhi: CCRUM; 2012. P. 45-49, 164, 324-44, 421-24, 427-73.
26. Ghanī N. Khazāīn-ul-Adviā, 3rd ed. New Delhi: Idara Kitab-ul-shifa; 2011. P. 272,793-5,835-6, 1012-3,1133-5,1260-1.
27. Khare CP. Indian Med Plants. 2nd ed. New Delhi: Springer (India) Private Limited; 2008. P. 289-90,527-8,555,566,710-1.
28. Kabiruddin M. Makhzan-ul-Mufradat Al- Maruf Khwas-ul-Advia. Deoband: Faisal publication; 2000. P. 336-7, 358-9, 433-5, 489-90, 494-5, 549-51.
29. Tarique AN. Taj-ul-Mufradat (Khawas-ul-Advia). New Delhi: Idara Kitab us Shifa; 2010. P. 14, 228-9, 451-3, 527-9, 607-8, 693-5.
30. Ibn Baitar. Al-Jameul Mufradat Al-Advia-wa-al-Aghzia (Urdu translation) Volume-1-4. New Delhi: CCRUM; 2003. P. 27-30, 122-5, 290-2, 300-04, 416-9.
31. Jahan Y, Siddiqui HH. Study of antitussive potential of Glycyrrhiza glabra and Adhatoda vasica using a cough model induced by sulphur dioxide gas in mice. IJPSR. 2012;3(6):1668-74.
32. Nirmala P, Selvaraj T. Anti-inflammatory and anti-bacterial activities of Glycyrrhiza glabra L. Journal of Agricultural Technology. 2011;7(3):815-23.
33. Nitalikar MM, Munde KC, Dhore BV, Shikalgar SN. Studies of antibacterial activities of Glycyrrhiza glabra root extract. Int J Pharm Tech Res. 2010;2(1):899-901.
34. Gupta VK, Fatima A, Faridi U, Negi AS, Shanker K, Kumar JK, et al. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol. 2008 Mar 5;116(2):377-80. https://doi.org/10.1016/j.jep.2007.11.037 PMid:18182260
35. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003;58(1):73-9. https://doi.org/10.1016/S0166-3542(02)00185-7 PMid:12719009
36. Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol. 2004;91(2-3):361-5. https://doi.org/10.1016/j.jep.2004.01.016 PMid:15120462
37. Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):449-54. https://doi.org/10.1016/j.pnpbp.2005.11.019 PMid:16443316
38. Awate SA, Patil RB, Ghode PD, Patole V, Pachauri D, Sherief SH. Aphrodisiac activity of aqueous extract of Glycyrrhiza glabra in male wistar rats. World Journal of Pharmaceutical Research. 2012; 1:371-8.
39. Nomura T, Fukai T, Akiyama T. Chemistry of phenolic compounds of liquorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities. Pure Appl. Chem. 2002;74(7):1199-206. https://doi.org/10.1351/pac200274071199
40. Kalani K, Agarwal J, Alam S, Khan F, Pal A, Srivastava SK. In silico and in vivo anti-malarial studies of 18β glycyrrhetinic acid from Glycyrrhiza glabra. PLoS one. 2013;8(9):74761. https://doi.org/10.1371/journal.pone.0074761 PMid:24086367 PMCid:PMC3782471
41. Ambawade SD, Kasture VS, Kasture SB. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Indian J Pharmacol. 2002;34(4):251-5.
42. Asha MK, Debraj D, Dethe S, Bhaskar A, Muruganantham N, Deepak M. Effect of flavonoid-rich extract of Glycyrrhiza glabra on gut-friendly microorganisms, commercial probiotic preparations and digestive enzymes. Journal of dietary supplements. 20174;14(3):323-33. https://doi.org/10.1080/19390211.2016.1223257 PMid:27588327
43. Mazumder PM, Pattnayak S, Parvani H, Sasmal D, Rathinavelusamy P. Evaluation of immunomodulatory activity of Glycyrrhiza glabra L roots in combination with zinc. Asian Pac J Trop Biomed. 2012 Jan 1;2(1):15-20. https://doi.org/10.1016/S2221-1691(12)60122-1
44. Jalilzadeh-Amin G, Najarnezhad V, Anassori E, Mostafavi M, Keshipour H. Antiulcer properties of Glycyrrhiza glabra L. extract on experimental models of gastric ulcer in mice. Iran J Pharm Res. 2015;14(4):1163-70.
45. Chauhan P, Sharma H, Kumar U, Mayachari A, Sangli G, Singh S. Protective effects of Glycyrrhiza glabra supplementation against methotrexate-induced hepato-renal damage in rats: An experimental approach. J Ethnopharmacol. 2020; 263:113209. https://doi.org/10.1016/j.jep.2020.113209 PMid:32738390
46. Lee CK, Park KK, Lim SS, Park JH, Chung WY. Effects of the liquorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer. Biol Pharm Bull. 2007;30(11):2191-5. https://doi.org/10.1248/bpb.30.2191 PMid:17978499
47. Ojha S, Golechha M, Kumari S, Bhatia J, Arya DS. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function. Experimental and toxicologic pathology. 2013;65(1-2):219-27. https://doi.org/10.1016/j.etp.2011.08.011 PMid:21975080
48. Lee JJ, Lee JH, Cho WK, Han JH, Ma JY. Herbal composition of Cinnamomum cassia, Pinus densiflora, Curcuma longa and Glycyrrhiza glabra prevents atherosclerosis by upregulating p27 (Kip1) expression. BMC Complement Altern Med. 2016;16(1):1-0. https://doi.org/10.1186/s12906-016-1224-8 PMid:27465365 PMCid:PMC4964310
49. Cheel J, Van Antwerpen P, Tůmová L, Onofre G, Vokurková D, Zouaoui-Boudjeltia K, Vanhaeverbeek M, Nève J. Free radical-scavenging, antioxidant and immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L.). Food Chemistry. 2010 Oct 1;122(3):508-17. https://doi.org/10.1016/j.foodchem.2010.02.060
50. Roy SD, Karmakar PR, Dash S, Biswajit D. Hair growth stimulating effect and phytochemical evaluation of hydro-alcoholic extract of Glycyrrhiza glabra. Global J Res. Med. Plants & Indigen. Med. 2014;3(2)40-7.
51. Fatima A, Gupta VK, Luqman S, Negi AS, Kumar JK, Shanker K, et al. Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin. Phytotherapy Research. 2009;23(8):1190-3. https://doi.org/10.1002/ptr.2726 PMid:19170157
52. Ambavade SD, Kasture VS, Kasture SB. Anxiolytic activity of Glycyrrhiza glabra Linn. Journal of natural remedies. 2001;1(2):130-4. DOI: https://doi.org/10.18311/jnr/2001/21
53. Raghav SK, Gupta B, Agrawal C, Goswami K, Das HR. Anti-inflammatory effect of Ruta graveolens L. in murine macrophage cells. J Ethnopharmacol. 2006;104(1-2):234-9. https://doi.org/10.1016/j.jep.2005.09.008 PMid:16207519
54. Ratheesh M, Helen A. Anti-inflammatory activity of Ruta graveolens Linn on carrageenan induced paw edema in wistar male rats. Afr. J. Biotechnol. 2007;6(10).1209-11.
55. Diwan R, Shinde A, Malpathak N. Phytochemical composition and antioxidant potential of Ruta graveolens L. in vitro culture lines. Journal of Botany. 2012;4. https://doi.org/10.1155/2012/685427
56. Preethi KC, Kuttan G, Kuttan R. Anti-tumour activity of Ruta graveolens extract. Asian Pacific J Cancer Prev. 2006;7(3):439-43.
57. Khouri NA, El-Akawi Z. Antiandrogenic activity of Ruta graveolens L. in male Albino rats with emphasis on sexual and aggressive behavior. Neuro Endocrinol Lett. 2005;26(6):823-9.
58. Kong YC, Lau CP, Wat KH, Ng KH, But PP, Cheng KF, et al. Antifertility principle of Ruta graveolens. Planta Med. 1989;55(02):176-8. https://doi.org/10.1055/s-2006-961917 PMid:2748734
59. Khori V, Nayebpour M, Semnani S, Golalipour MJ, Marjani A. Prolongation of AV nodal refractoriness by Ruta graveolens in isolated rat hearts. Saudi Med J. 2008;29(3):357-63
60. Azalework HG, Sahabjada AJ, Md Arshad TM. Phytochemical investigation, GC-MS profile and antimicrobial activity of a medicinal plant Ruta graveolens L. from Ethiopia. Int J Pharm Sci. 2017;9(6):29-34. https://doi.org/10.22159/ijpps.2017v9i6.16812
61. Ahmed OM, Moneim AA, Yazid IA, Mahmoud AM. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats. Diabetologia croatica. 2010;39(1):15-35.
62. Loonat F, Amabeoku GJ. Antinociceptive, anti-inflammatory and antipyretic activities of the leaf methanol extract of Ruta graveolens L. (Rutaceae) in mice and rats. Afr J Tradit Complement Altern Med. 2014;11(3):173-81. https://doi.org/10.4314/ajtcam.v11i3.25 PMid:25371580 PMCid:PMC4202436
63. Harat ZN, Sadeghi MR, Sadeghipour HR, Kamalinejad M, Eshraghian MR. Immobilization effect of Ruta graveolens L. on human sperm: a new hope for male contraception. J Ethnopharmacol. 2008;115(1):36-41. https://doi.org/10.1016/j.jep.2007.09.004 PMid:18029123
64. Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS, Ratnasooriya WD. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopharmacol. 2003;87(2-3):199-206. https://doi.org/10.1016/S0378-8741(03)00159-4 PMid:12860308
65. Tiwari OP, Tripathi YB. Antioxidant properties of different fractions of Vitex negundo Linn. Food Chemistry. 2007;100(3):1170-6. https://doi.org/10.1016/j.foodchem.2005.10.069
66. Malik A, Khan MT, Khan SB, Ahmad A, Choudhary MI. Tyrosinase inhibitory lignans from the methanol extract of the roots of Vitex negundo Linn. and their structure-activity relationship. Phytomedicine. 2006;13(4):255-60. https://doi.org/10.1016/j.phymed.2004.09.001 PMid:16492528
67. Chitra V, Sharma S, Kayande N. Evaluation of anticancer activity of Vitex negundo in experimental animals: an in vitro and in vivo study. Int. J. PharmTech Res. 2009;1(4):1485-9.
68. Kamruzzaman M, Bari SN, Faruque SM. In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens. Asian Pac J Trop Med. 2013;6(5):352-9. https://doi.org/10.1016/S1995-7645(13)60038-3 PMid:23608373
69. Zargar M, Hamid AA, Bakar FA, Shamsudin MN, Shameli K, Jahanshiri F, et al. Green synthesis and antibacterial effect of silver nanoparticles using Vitex negundo L. Molecules. 2011;16(8):6667-76. https://doi.org/10.3390/molecules16086667 PMid:25134770 PMCid:PMC6264443
70. Sahare KN, Singh V. Antifilarial activity of ethyl acetate extract of Vitex negundo leaves in vitro. Asian Pac J Trop Med. 2013;6(9):689-92. https://doi.org/10.1016/S1995-7645(13)60119-4 PMid:23827144
71. Mahmud S, Shareef H, Farrukh U, Kamil A, Rizwani GH. Antifungal activities of Vitex negundo Linn. Pak. J. Bot. 2009;41(4):1941-3.
72. Adnaik RS, Pai PT, Sapakal VD, Naikwade NS, Magdum CS. Anxiolytic activity of Vitex negundo Linn. in experimental models of anxiety in mice. International Journal of Green Pharmacy (IJGP). 2009;3(3).243-7. https://doi.org/10.4103/0973-8258.56284
73. Adnaik RS, Pai PT, Mule SN, Naikwade NS, Magdum CS. Laxative activity of Vitex negundo Linn. Leaves. Asian J. Exp. Sci. 2008;22(1):159-60.
74. Tandon VR, Khajuria V, Kapoor B, Kour D, Gupta S. Hepatoprotective activity of Vitex negundo leaf extract against anti-tubercular drugs induced hepatotoxicity. Fitoterapia. 2008;79(7-8):533-8. https://doi.org/10.1016/j.fitote.2008.05.005 PMid:18621114
75. Haq RU, Shah AU, Khan AU, et al. Antitussive and toxicological evaluation of Vitex negundo. Nat Prod Res. 2012;26(5):484-8. https://doi.org/10.1080/14786419.2010.534472 PMid:21809956
76. Hu Y, Zhang QY, Hou TT, et al. Estrogen-like activities in Vitex species from China determined by a cell-based proliferation assay. Pharmazie. 2007;62(11):872-5.
77. Nair AM, Saraf MN. Inhibition of antigen and compound 48/80 induced contractions of guinea pig trachea by the ethanolic extract of the leaves of Vitex negundo Linn. Indian Journal of Pharmacology. 1995;27(4):230-3.
78. Sayyah M, Hadidi N, Kamalinejad M. Analgesic and anti-inflammatory activity of Lactuca sativa seed extract in rats. J Ethnopharmacol. 2004;92(2-3):325-9. https://doi.org/10.1016/j.jep.2004.03.016 PMid:15138019
79. Ismail H, Mirza B. Evaluation of analgesic, anti-inflammatory, anti-depressant and anti-coagulant properties of Lactuca sativa (CV. Grand Rapids) plant tissues and cell suspension in rats. BMC Complement Altern Med. 2015;15(1):1-7. https://doi.org/10.1186/s12906-015-0742-0 PMid:26115918 PMCid:PMC4482268
80. Said SA, Kashef HA, Mazar MM, Salama O. Phytochemical and pharmacological studies on Lactuca sativa seed oil. Pharmacy. 1996;244.
81. Harsha SN, Anilakumar KR. Anxiolytic property of Lactuca sativa, effect on anxiety behaviour induced by novel food and height. Asian Pac J Trop Med. 2013;6(7):532-6. https://doi.org/10.1016/S1995-7645(13)60091-7 PMid:23768824
82. Garg M, Garg C, Mukherjee PK, Suresh B. Antioxidant potential of Lactuca sativa. Anc Sci Life. 2004;24(1):6-10.
83. Edziri HÁ, Smach MA, Ammar S, et al. Antioxidant, antibacterial, and antiviral effects of Lactuca sativa extracts. Industrial Crops and Products. 2011;34(1):1182-5. https://doi.org/10.1016/j.indcrop.2011.04.003
84. Moghadam MH, Ghasemi Z, Sepahi S, Rahbarian R, Mozaffari HM, Mohajeri SA. Hypolipidemic effect of Lactuca sativa seed extract, an adjunctive treatment, in patients with hyperlipidemia: a randomized double-blind placebo-controlled pilot trial. Journal of Herbal Medicine. 2020; 23:100373. https://doi.org/10.1016/j.hermed.2020.100373
85. Nie C, Zhu P, Ma S, Wang M, Hu Y. Purification, characterization and immunomodulatory activity of polysaccharides from stem lettuce. Carbohydr Polym. 2018; 188:236-42. https://doi.org/10.1016/j.carbpol.2018.02.009 PMid:29525161
86. Sadeghnia HR, Farahm SK, Asadpour E, Rakhsh H, Ghorbani A. Neuroprotective effect of Lactuca sativa on glucose/serum deprivation-induced cell death. African Journal of Pharmacy and pharmacology. 2012;6(33):2464-71. https://doi.org/10.5897/AJPP12.085
87. Ansari AN, Sherwani AM, Shamshad A. Clinical evaluation of a Unani herbal formulation in Zaghtul-Dam Qavi Ibtadai (primary hypertension). Hamdard Medicus. 2009;52(3):51-7.
88. Qin XX, Zhang MY, Han YY, Hao JH, Liu CJ, Fan SX. Beneficial phytochemicals with anti-tumor potential revealed through metabolic profiling of new red pigmented lettuces (Lactuca sativa L.). Int. J. Mol. Sci. 2018;19(4):1165. https://doi.org/10.3390/ijms19041165 PMid:29641499 PMCid:PMC5979491
89. Lee CJ, Chen LG, Liang WL, Wang CC. Anti-inflammatory effects of Punica granatum Linn. in vitro and in vivo. Food chemistry. 2010;118(2):315-22. https://doi.org/10.1016/j.foodchem.2009.04.123
90. Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food MIcrobiol. 2009;134(3):244-8. https://doi.org/10.1016/j.ijfoodmicro.2009.07.002 PMid:19632734
91. Pfohl M, DaSilva NA, Marques E, Agudelo J, Liu C, Goedken M, et al. Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. Int J Food Sci Nutr. 2021;72(4):499-510. https://doi.org/10.1080/09637486.2020.1849041 PMid:33203257
92. Bhaskar A, Kumar A. Antihyperglycemic, antioxidant and hypolipidemic effect of Punica granatum L. flower extract in streptozotocin induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2012;2(3): S1764-9. https://doi.org/10.1016/S2221-1691(12)60491-2
93. Lavaee F, Motaghi D, Jassbi AR, Jafarian H, Ghasemi F, Badiee P. Antifungal effect of the bark and root extracts of Punica granatum on oral Candida isolates. Curr Med Mycol. 2018 ;4(4):20-4. https://doi.org/10.18502/cmm.4.4.382 PMid:30815613 PMCid:PMC6386507
94. Das AK, Mandal SC, Banerjee SK, Sinha S, Das J, Saha BP, Pal M. Studies on antidiarrhoeal activity of Punica granatum seed extract in rats. Journal of ethnopharmacology. 1999;68(1-3):205-8. https://doi.org/10.1016/S0378-8741(99)00102-6 PMid:10624879
95. Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, Reliene R. Antiproliferative effects of pomegranate extract in MCF‐7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog. 2014;53(6):458-70. https://doi.org/10.1002/mc.21995 PMid:23359482
96. Razani Z, Dastani M, Kazerani HR. Cardioprotective effects of pomegranate (Punica granatum) juice in patients with ischemic heart disease. Phytother Res. 2017;31(11):1731-8. https://doi.org/10.1002/ptr.5901 PMid:28913846
97. Chidambara Murthy KN, Reddy VK, Veigas JM, Murthy UD. Study on wound healing activity of Punica granatum peel. J Med Food. 2004;7(2):256-9. https://doi.org/10.1089/1096620041224111 PMid:15298776
98. Salgado AD, Maia JL, Pereira SL, Lemos TL, Mota OM. Antiplaque and antigingivitis effects of a gel containing Punica granatum Linn extract: a double-blind clinical study in humans. J Appl Oral Sci. 2006;14(3):162-6. https://doi.org/10.1590/S1678-77572006000300003 PMid:19089066 PMCid:PMC4327190
99. Ross RG, Selvasubramanian S, Jayasundar S. Immunomodulatory activity of Punica granatum in rabbits-a preliminary study. J Ethnopharmacol. 2001;78(1):85-7. https://doi.org/10.1016/S0378-8741(01)00287-2 PMid:11585693
100. Barwal SB, Sunil AN, Dhasade VV, Patil MJ, Pal SC, Subhash CM. Antihistaminic effect of various extracts of Punica granatum Linn. flower buds. J Young Pharm. 2009;1(4):322-25. https://doi.org/10.4103/0975-1483.59321
101. Basim E, Basim H. Antibacterial activity of Rosa damascena essential oil. Fitoterapia. 2003;74(4):394-6. https://doi.org/10.1016/S0367-326X(03)00044-3 PMid:12781814
102. Liu WY, Chen LY, Huang YY, Fu L, Song LY, Wang YY, et al. Antioxidation and active constituents' analysis of flower residue of Rosa damascena. Chinese Herbal Medicines. 2020;12(3):336-41. https://doi.org/10.1016/j.chmed.2020.05.005 PMid:36119007 PMCid:PMC9476380
103. Homayoun M, Seghatoleslam M, Pourzaki M, Shafieian R, Hosseini M, Bideskan AE. Anticonvulsant and neuroprotective effects of Rosa damascena hydro-alcoholic extract on rat hippocampus. Avicenna J phytomed. 2015;5(3):260-70.
104. Hajhashemi V, Ghannadi A, Hajiloo M. Analgesic and anti-inflammatory effects of Rosa damascena hydroalcoholic extract and its essential oil in animal models. Iran J Pharm Res. 2010;9(2):163-8.
105. Tirupathi H, Golla P. To evaluate and compare antidepressant activity of Rosa damascena in mice by using forced swimming test. Int J Basic Clin Pharmacol. 2016; 5:1949-52. https://doi.org/10.18203/2319-2003.ijbcp20163217
106. Mohammadi A, Fallah H, Gholamhosseinian A. Antihyperglycemic effect of Rosa damascena is mediated by PPAR. γ gene expression in animal model of insulin resistance. Iran J Pharm Res. 2017;16(3):1080-8.
107. Slavov A, Kiyohara H, Yamada H. Immunomodulating pectic polysaccharides from waste rose petals of Rosa damascena Mill. Int J Biol Macromol. 2013; 59:192-200. https://doi.org/10.1016/j.ijbiomac.2013.04.054 PMid:23624286
108. Khare S, Gupta M, Cheema HS, Maurya AK, Rout P, Darokar MP, et al. Rosa damascena restrains Plasmodium falciparum progression in vitro and impedes malaria pathogenesis in murine model. Biomed Pharmacother. 2018; 97:1654-62. https://doi.org/10.1016/j.biopha.2017.11.130 PMid:29793328
109. Baniasad A, Khajavirad A, Hosseini M, Shafei MN, Aminzadah S, Ghavi M. Effect of hydro-alcoholic extract of Rosa damascena on cardiovascular responses in normotensive rat. Avicenna J Phytomed. 2015;5(4):319-24.
110. Bani S, Hasanpour S, Mousavi Z, Garehbaghi PM, Gojazadeh M. The effect of Rosa damascena extract on primary dysmenorrhea: a double-blind cross-over clinical trial. Iran Red Crescent Med J. 2014 Jan;16(1):14643. https://doi.org/10.5812/ircmj.14643 PMid:24719710 PMCid:PMC3964428
111. Shafei MN, Rakhshandah H, Boskabady MH. Antitussive effect of Rosa damascena in guinea pigs. Iranian Journal of Pharmaceutical Research. 2003; 2:231-4.
112. Arezoomandan R, Kazerani HR, Behnam RM. The laxative and prokinetic effects of Rosa damascena Mill in rats. Iran J Basic Med Sci. 2011;14(1):9-16. http://dx.doi.org/10.22038/IJBMS.2011.4948
113. Boskabady MH, Vatanprast A, Parsee H, Ghasemzadeh M. Effect of aqueous-ethanolic extract from Rosa damascena on guinea pig isolated heart. Iran J Basic Med Sci. 2011;14(2):116-21. http://dx.doi.org/10.22038/IJBMS.2011.4974
114. Jurjani AH. Zakhira Khawarzam Shahi. (Urdu translation by Husain H), Vol. VI, New Delhi: Idara Kitab-ul-shifa; 2000. P. 571-3.
115. Ibn Hubal. Kitab al-Mukhtarat fit-Tib (Urdu translation), Vol. IV, New Delhi: CCRUM; 2005. P. 25-6.
116. Shah A, Nighat A, Asim AK, Jamal A, Fouzia B, Naheed P, Shamim, Surʻat-e-Inzāl (Premature Ejaculation) and its Management by Unani Medicine, Journal of Drug Delivery and Therapeutics. 2019; 9(4-s):641-647 http://dx.doi.org/10.22270/jddt.v9i4-s.3218
Crossmark
Statistics
93 Views | 12 Downloads
How to Cite
1.
Ahmad W, Siddiqui JI, Naikodi MAR, USMANI QI. Safūf-i Aslussūs: A time-tested polyherbal formulation for the management of Premature Ejaculation- A comprehensive review. JDDT [Internet]. 15Jun.2024 [cited 17Jul.2024];14(6):191-9. Available from: https://jddtonline.info/index.php/jddt/article/view/6618